Progenity is a biotech company with a multi-omics approach.
We are combining genomics, epigenomics, proteomics, and metabolomics to improve the diagnosis and treatment of disease.
About UsTransforming healthcare to be more precise and personal.
Latest News
- Progenity Announces Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of Gastroenterology January 11, 2022
- Progenity Announces Acceptance of Two Abstracts on Treatment of Gastrointestinal Disorders at ECCO'22 January 5, 2022
Featured Publications
- Development of a novel drug delivery system to deliver drugs directly... The DDS2 system could result in improved efficacy and reduced systemic exposure for the treatment of ulcerative colitis. Aug 30, 2021
- Targeted delivery of tofacitinib citrate to the site of disease to improve... When delivered to the site of inflammation, liquid drug formulations could result in higher tissue absorption and lower drug exposure. May 20, 2021